ESG risk score 25.88
Environmental score -
Social score -
Governance score -
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Zai Lab Ltd - ADR
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol ZLAB:xnas
Currency USD
NASDAQ
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Ready to start investing?
Trade stocks with a regulated broker present in Singapore since 2006.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) 16.21%
1 year -35.47%
3 years -38.49%
Data provided by 
Key stats
Price/earnings (LTM) -
Dividend yield (LTM) -
EPS (LTM) -1.61
Volatility (30 days) 55.43%
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Zai Lab Ltd - ADR
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Sector Healthcare
Industry -
Market cap 2bn
Data provided by /
/ Frequently asked questions
You need to open and fund a Saxo account to buy Zai Lab Ltd - ADR stock. Once the account is approved, you can login to the platform (SaxoInvestor or SaxoTrader), search for Zai Lab Ltd - ADR (by name) or ‘APPL’ (by ticker), choose the number of shares you wish to buy, and place your order.
The ticker symbol for Zai Lab Ltd - ADR is ZLAB:xnas. You can use this code to find the stock in our platforms and track its price and performance.
Zai Lab Ltd - ADR has its primary listing on NASDAQ. You can trade Zai Lab Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Zai Lab Ltd - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy Zai Lab Ltd - ADR stock directly and include it as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Zai Lab Ltd - ADR or others.